HBK Sorce Advisory’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.88M Sell
4,423
-525
-11% -$269K 0.04% 157
2025
Q4
$2.68M Sell
4,948
-465
-9% -$264K 0.06% 127
2025
Q3
$2.78M Sell
5,413
-168
-3% -$73.3K 0.07% 119
2025
Q2
$1.75M Buy
5,581
+176
+3% +$52.8K 0.05% 153
2025
Q1
$1.65M Buy
5,405
+21
+0.4% +$7.06K 0.05% 153
2024
Q4
$1.79M Buy
5,384
+29
+0.5% +$9.84K 0.05% 147
2024
Q3
$1.79M Sell
5,355
-271
-5% -$103K 0.05% 146
2024
Q2
$2.32M Sell
5,626
-806
-13% -$319K 0.08% 123
2024
Q1
$2.6M Sell
6,432
-190
-3% -$66.8K 0.09% 117
2023
Q4
$2.03M Sell
6,622
-536
-7% -$145K 0.08% 139
2023
Q3
$1.73M Sell
7,158
-76
-1% -$19.4K 0.08% 141
2023
Q2
$1.74M Sell
7,234
-1,501
-17% -$312K 0.07% 153
2023
Q1
$1.64M Sell
8,735
-9,535
-52% -$1.97M 0.07% 154
2022
Q4
$3.88M Buy
18,270
+8,755
+92% +$1.75M 0.1% 134
2022
Q3
$1.5M Buy
9,515
+3,199
+51% +$510K 0.1% 137
2022
Q2
$945K Sell
6,316
-470
-7% -$68K 0.07% 161
2022
Q1
$1.11M Buy
6,786
+1,027
+18% +$169K 0.06% 191
2021
Q4
$1.25M Buy
+5,759
New +$1.21M 0.06% 190

Other funds holding MEDP

HBK Sorce Advisory's MEDP Position: Q1 2026 in Review

HBK Sorce Advisory reduced its Medpace (MEDP) stake by 11% in Q1 2026, selling an estimated $269K and leaving 4,423 shares worth $1.88M. The position accounts for 0.04% of the portfolio, ranked #157.

HBK Sorce Advisory first reported a position in MEDP in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.88M in Q4 2022. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • HBK Sorce Advisory held 4,423 shares of Medpace worth $1.88M as of Q1 2026.
  • HBK Sorce Advisory sold 525 Medpace shares in Q1 2026, an estimated $269K.
  • Medpace made up 0.04% of HBK Sorce Advisory's portfolio in Q1 2026, its #157 holding.
  • HBK Sorce Advisory first reported a position in Medpace in Q4 2021 and has held it in 18 quarters since.
  • HBK Sorce Advisory's Medpace position peaked at $3.88M in Q4 2022.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on HBK Sorce Advisory's 13F filing for Q1 2026, filed 11 May 2026.